<DOC>
	<DOCNO>NCT02263924</DOCNO>
	<brief_summary>Phase III , single-centre , double-blind , randomised , placebo-controlled , parallel-group trial evaluate efficacy safety oral Vitamin E ( Mixed Tocotrienol ) 6 month patient moderate ischemic stroke . 150 patient recruit . Half receive mixed tocotrienol 200mg twice day 6 month half receive placebo capsule .</brief_summary>
	<brief_title>Stroke Tocotrienol : Unique Role Neuroprotection</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<criteria>Age 35 year old Subject include within time frame 110 day first onset acute cerebral ischemic stroke NIHSS 620 Subject neurologically stable stroke onset , i.e . fluctuation clinical condition . Subject Modified Rankin Scale 24 Subject clinical stroke diagnosis accord WHO stroke diagnosis Subject willing attend least four session physiotherapy study deem needed physiotherapist Subject his/her legally accepted representative willing provide write informed consent Subject evidence intracerebral hemorrhage brain CT scan MRI Severe stroke assess clinically and/or appropriate imaging technique Subject significant nonischemic brain lesion ( ) could affect function disability Time ischemic stroke onset exactly know Subject coexist systemic disease may affect assessment followup terminal cancer , renal failure ( serum creatinine &gt; 200umol/L know ) , liver cirrhosis , severe dementia psychosis , connective tissue disease , rheumatoid arthritis Subject significant liver impairment ( liver function test five time upper limit level ) Subject definite indication full dose longterm anticoagulation therapy ( warfarin ) Any condition judgement investigator would place patient undue risk Traumatic brain injury within previous 30days Symptoms rapidly improve ( transient ischemic stroke ) Patient recurrent stroke The patient female childbearing potential ( unless subject contraception measurement ) breast feeding Patients include clinical trial within previous three month</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>